Press Releases

GI Dynamics Closes an Additional $15 Million in Series C Financing

Lexington, Mass., February 19, 2009 – GI Dynamics today announced that it has closed an additional $15 million in Series C financing. With this additional funding, GI Dynamics has closed a total of $45 million in Series C financing, bringing the total raised by GI Dynamics since its inception to...

read more

GI Dynamics Receives ISO Certification and European CE Mark Approval for the EndoBarrier™ Gastrointestinal Liner System

Lexington, MA, January 7, 2009 – GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and metabolic disorders, today announced that it has received ISO 13485:2003 certification for the company’s Lexington facility. The company has also received...

read more

New Data in Journal Obesity Demonstrate that a Noninvasive, Removable Medical Device Results in Substantial Weight Loss and Glucose Normalization in a Preclinical Model of Obesity

Data Support Weight Loss and Glucose Results Observed in Clinical Trials of EndoBarrier™; Study Recognized by Obesity Society at 2008 Annual Meeting  LEXINGTON, Mass., November 18, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and type 2...

read more

GI Dynamics Announces Promising Multi-Center Safety and Efficacy Data of EndoBarrier™ Gastrointestinal Liner for Pre-Surgical Weight Loss

New Clinical Data Presented at IFSO Show Excellent Short Term Weight Loss Results in Morbidly Obese Patients Buenos Aires, Argentina, September 26, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treat obesity and metabolic disorders, today announced...

read more

GI Dynamics to Present Data from Clinical Weight Loss Study of EndoBarrier™ Gastrointestinal Liner in Morbidly Obese Patients at the International Federation for Surgery of Obesity and Metabolic Disorders (IFSO) 13th World Congress

(IFSO) 13th World Congress LEXINGTON, Mass., September 19, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier™, its novel, noninvasive device currently in clinical trials to...

read more

GI Dynamics Announces Data Demonstrating Immediate and Sustained Reduction in HbA1c in Patients with Type 2 Diabetes Using EndoBarrier™ Gastrointestinal Liner

Compelling Clinical Data Highlighted at First World Congress on Interventional Therapies for Type 2 Diabetes Show Improved Glycemic Control and Weight Reduction in Uncontrolled Diabetics NEW YORK, NY, September 16, 2008 – GI Dynamics, a medical device company pioneering the development of new...

read more

Data from Clinical Trial of EndoBarrier™ Gastrointestinal Liner in Patients with Type 2 Diabetes to be Presented at the First World Congress on Interventional Therapies for Type 2 Diabetes in New York

LEXINGTON, Mass., September 9, 2008 – GI Dynamics, a medical device company pioneering the development of new approaches to treating metabolic disorders, today announced that new data regarding EndoBarrier™, its novel, noninvasive device currently in clinical trials to treat obesity and type 2...

read more
Page 17 of 17« First...10...1314151617